Psychiatric disorders in smokers seeking treatment for tobacco dependence: Relations with tobacco dependence and cessation.
- 1 February 2010
- journal article
- research article
- Published by American Psychological Association (APA) in Journal of Consulting and Clinical Psychology
- Vol. 78 (1) , 13-23
- https://doi.org/10.1037/a0018065
Abstract
The present research examined the relation of psychiatric disorders to tobacco dependence and cessation outcomes. Data were collected from 1,504 smokers (58.2% women; 83.9% White; mean age = 44.67 years, SD = 11.08) making an aided smoking cessation attempt as part of a clinical trial. Psychiatric diagnoses were determined with the Composite International Diagnostic Interview structured clinical interview. Tobacco dependence was assessed with the Fagerström Test of Nicotine Dependence (FTND) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Diagnostic groups included those who were never diagnosed, those who had ever been diagnosed (at any time, including in the past year), and those with past-year diagnoses (with or without prior diagnosis). Some diagnostic groups had lower follow-up abstinence rates than did the never diagnosed group (ps < .05). At 8 weeks after quitting, strong associations were found between cessation outcome and both past-year mood disorder and ever diagnosed anxiety disorder. At 6 months after quitting, those ever diagnosed with an anxiety disorder (OR = .72, p = .02) and those ever diagnosed with more than one psychiatric diagnosis (OR = .74, p = .03) had lower abstinence rates. The diagnostic categories did not differ in smoking heaviness or the FTND, but they did differ in dependence motives assessed with the WISDM. Information on recent or lifetime psychiatric disorders may help clinicians gauge relapse risk and may suggest dependence motives that are particularly relevant to affected patients. These findings also illustrate the importance of using multidimensional tobacco dependence assessments.Keywords
Funding Information
- National Institutes of Health (P50 DA019706, M01 RR03186)
- University of Wisconsin—Madison (1KL2RR025012-01)
- National Cancer Institute (1K05CA139871)
- GlaxoSmithKline
- Elan Corporation, plc.
This publication has 67 references indexed in Scilit:
- Do smokers know what we're talking about? The construct validity of nicotine dependence questionnaire measures.Psychological Assessment, 2009
- A Randomized Placebo-Controlled Clinical Trial of 5 Smoking Cessation PharmacotherapiesArchives of General Psychiatry, 2009
- Differences between daily smokers, chippers, and nonsmokers with co-occurring anxiety and alcohol-use disordersAddictive Behaviors, 2008
- Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives.Journal of Abnormal Psychology, 2008
- The Collective Dynamics of Smoking in a Large Social NetworkNew England Journal of Medicine, 2008
- Drug use in the social networks of heroin and cocaine users before and after drug cessationDrug and Alcohol Dependence, 2008
- Correlates of smoking cessation in a nationally representative sample of U.S. adultsAddictive Behaviors, 2008
- The role of psychiatric disorders in the relationship between cigarette smoking and DSM-IV nicotine dependence among young adultsNicotine & Tobacco Research, 2008
- Time to first cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependenceNicotine & Tobacco Research, 2007
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991